{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:40:48Z","timestamp":1791290448041,"version":"4.3.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH121424"],"award-info":[{"award-number":["R01 MH121424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K01AG071843"],"award-info":[{"award-number":["K01AG071843"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Washington Behavioral Research Center for HIV"},{"name":"University of Washington Behavioral Research Center for HIV","award":["P30 MH123248"],"award-info":[{"award-number":["P30 MH123248"]}]},{"name":"University of Washington Behavioral Research Center for HIV","award":["P30 MH123248"],"award-info":[{"award-number":["P30 MH123248"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12804-x","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:25:00Z","timestamp":1770776700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient preferences for long-acting antiretroviral treatment among people with HIV in Kenya: a discrete choice experiment"],"prefix":"10.1186","volume":"26","author":[{"given":"Jacinda","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique M.","family":"Saldarriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kaggiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naum","family":"Jepkosgei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Barthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Hauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kinuthia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"12804_CR1","unstructured":"The path that ends AIDS. UNAIDS Global AIDS Update 2023."},{"key":"12804_CR2","unstructured":"The Urgency of Now. AIDS at a Crossroads \u2014 2024 global AIDS update. 2024."},{"key":"12804_CR3","unstructured":"UNAIDS Country Factsheet. Kenya 2022 [Internet]. UNAIDS; [cited 2023 Nov 21]. Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/kenya."},{"key":"12804_CR4","doi-asserted-by":"crossref","unstructured":"Onyango MA, Chergui H, Sabin LL, Messersmith LJ, Sarkisova N, Oyombra J, et al. School-level barriers of antiretroviral therapy adherence and interventions to overcome them among adolescents living with HIV in Western Kenya: a qualitative study. Open AIDS J. 2021 Dec 31 [cited 2024 Feb 13];15(1). Available from: https:\/\/openaidsjournal.com\/VOLUME\/15\/PAGE\/93\/.","DOI":"10.2174\/1874613602115010093"},{"key":"12804_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.puhe.2017.12.010","volume":"157","author":"N Ammon","year":"2018","unstructured":"Ammon N, Mason S, Corkery JM. Factors impacting antiretroviral therapy adherence among human immunodeficiency virus\u2013positive adolescents in Sub-Saharan africa: a systematic review. Public Health. 2018;157:20\u201331.","journal-title":"Public Health"},{"issue":"8","key":"12804_CR6","doi-asserted-by":"publisher","first-page":"e003028","DOI":"10.1136\/bmjopen-2013-003028","volume":"3","author":"CJ Cohen","year":"2013","unstructured":"Cohen CJ, Meyers JL, Davis KL. Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV. BMJ Open. 2013;3(8):e003028.","journal-title":"BMJ Open"},{"issue":"11","key":"12804_CR7","doi-asserted-by":"publisher","first-page":"e1002183","DOI":"10.1371\/journal.pmed.1002183","volume":"13","author":"Z Shubber","year":"2016","unstructured":"Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient-Reported barriers to adherence to antiretroviral therapy: A systematic review and Meta-Analysis. PLoS Med. 2016;13(11):e1002183.","journal-title":"PLoS Med"},{"issue":"5","key":"12804_CR8","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1016\/S2352-3018(23)00051-6","volume":"10","author":"JB Nachega","year":"2023","unstructured":"Nachega JB, Scarsi KK, Gandhi M, Scott RK, Mofenson LM, Archary M, et al. Long-acting antiretrovirals and HIV treatment adherence. Lancet HIV. 2023;10(5):e332\u201342.","journal-title":"Lancet HIV"},{"key":"12804_CR9","unstructured":"Rana AI, Bao Y, Zheng L, Sieczkarski S, Lake JE, Long-acting injectable. CAB\/RPV is superior to oral ART in PWH with adherence challenges: ACTG A5359 [Internet]. In: Conference on Retroviruses and Opportunistic Infections (CROI) 2024; 2024 Mar 7 [cited 2024 Aug 4]. Available from: https:\/\/www.croiconference.org\/abstract\/long-acting-injectable-cab-rpv-is-superior-to-oral-art-in-pwh-with-adherence-challenges-actg-a5359\/."},{"issue":"12","key":"12804_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMoa1904398","volume":"382","author":"S Swindells","year":"2020","unstructured":"Swindells S, Andrade-Villanueva JF, Richmond GJ, Rizzardini G, Baumgarten A, Masi\u00e1 M, et al. Long-Acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression. N Engl J Med. 2020;382(12):1112\u201323.","journal-title":"N Engl J Med"},{"issue":"12","key":"12804_CR11","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","volume":"382","author":"C Orkin","year":"2020","unstructured":"Orkin C, Arasteh K, G\u00f3rgolas Hern\u00e1ndez-Mora M, Pokrovsky V, Overton ET, Girard PM, et al. Long-Acting cabotegravir and rilpivirine after oral induction for HIV-1 infection. N Engl J Med. 2020;382(12):1124\u201335.","journal-title":"N Engl J Med"},{"issue":"11","key":"12804_CR12","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1016\/S2352-3018(21)00185-5","volume":"8","author":"H Jaeger","year":"2021","unstructured":"Jaeger H, Overton ET, Richmond G, Rizzardini G, Andrade-Villanueva JF, Mngqibisa R, et al. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2\u00a0M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. Lancet HIV. 2021;8(11):e679\u201389.","journal-title":"Lancet HIV"},{"key":"12804_CR13","doi-asserted-by":"crossref","unstructured":"John M, Williams L, Nolan G, Bonnett M, Castley A, Nolan D. Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS). HIV Med. 2024 Apr [cited 2024 Jul 7];n\/a. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/hiv.13647.","DOI":"10.1111\/hiv.13647"},{"issue":"10","key":"12804_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1473-3099(24)00289-5","volume":"24","author":"C Kityo","year":"2024","unstructured":"Kityo C, Mambule IK, Musaazi J, Sokhela S, Mugerwa H, Ategeka G, et al. Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial. Lancet Infect Dis. 2024;24(10):1083\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"12804_CR15","doi-asserted-by":"publisher","first-page":"e10237","DOI":"10.1002\/btm2.10237","volume":"7","author":"J Beloor","year":"2021","unstructured":"Beloor J, Kudalkar SN, Buzzelli G, Yang F, Mandl HK, Rajashekar JK, et al. Long-acting and extended\u2010release implant and nanoformulations with a synergistic antiretroviral two\u2010drug combination controls HIV\u20101 infection in a humanized mouse model. Bioeng Transl Med. 2021;7(1):e10237.","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"12804_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/COH.0000000000000591","volume":"15","author":"ED Weld","year":"2020","unstructured":"Weld ED, Flexner C. Long-acting implants to treat and prevent HIV infection. Curr Opin HIV AIDS. 2020;15(1):33\u201341.","journal-title":"Curr Opin HIV AIDS"},{"issue":"19","key":"12804_CR17","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","volume":"386","author":"S Segal-Maurer","year":"2022","unstructured":"Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, et al. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 infection. N Engl J Med. 2022;386(19):1793\u2013803.","journal-title":"N Engl J Med"},{"issue":"9","key":"12804_CR18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/17425247.2020.1783233","volume":"17","author":"DA Cobb","year":"2020","unstructured":"Cobb DA, Smith NA, Edagwa BJ, McMillan JM. Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research. Expert Opin Drug Deliv. 2020;17(9):1227\u201338.","journal-title":"Expert Opin Drug Deliv"},{"key":"12804_CR19","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.eclinm.2020.100453","volume":"25","author":"J Culhane","year":"2020","unstructured":"Culhane J, Sharma M, Wilson K, Roberts DA, Mugo C, Wamalwa D, et al. Modeling the health impact and cost threshold of long-acting ART for adolescents and young adults in Kenya. EClinicalMedicine. 2020;25:100453.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"12804_CR20","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1016\/S2214-109X(21)00025-5","volume":"9","author":"AN Phillips","year":"2021","unstructured":"Phillips AN, Bansi-Matharu L, Cambiano V, Ehrenkranz P, Serenata C, Venter F, et al. The potential role of long-acting injectable cabotegravir\u2013rilpivirine in the treatment of HIV in sub-Saharan africa: a modelling analysis. Lancet Glob Health. 2021;9(5):e620\u20137.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"12804_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/apc.2018.0198","volume":"33","author":"JM Simoni","year":"2019","unstructured":"Simoni JM, Beima-Sofie K, Mohamed ZH, Christodoulou J, Tapia K, Graham SM, et al. Long-Acting injectable antiretroviral treatment acceptability and preferences: A qualitative study among US Providers, adults living with HIV, and parents of youth living with HIV. AIDS Patient Care STDS. 2019;33(3):104\u201311.","journal-title":"AIDS Patient Care STDS"},{"key":"12804_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12981-022-00435-6","volume":"19","author":"AT Brah","year":"2022","unstructured":"Brah AT, Barthold D, Hauber B, Collier AC, Ho RJY, Marconi VC, et al. The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the united States. AIDS Res Ther. 2022;19:13.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"12804_CR23","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s10461-019-02701-7","volume":"24","author":"JM Simoni","year":"2020","unstructured":"Simoni JM, Tapia K, Lee SJ, Graham SM, Beima-Sofie K, Mohamed ZH, et al. A conjoint analysis of the acceptability of targeted Long-Acting injectable antiretroviral therapy among persons living with HIV in the U.S. AIDS Behav. 2020;24(4):1226\u201336.","journal-title":"AIDS Behav"},{"issue":"5","key":"12804_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40271-022-00581-z","volume":"15","author":"D Barthold","year":"2022","unstructured":"Barthold D, Brah AT, Graham SM, Simoni JM, Hauber B. Improvements to survey design from pilot testing a Discrete-Choice experiment of the preferences of persons living with HIV for Long-Acting antiretroviral therapies. Patient. 2022;15(5):513\u201320.","journal-title":"Patient"},{"issue":"Suppl 2","key":"12804_CR25","doi-asserted-by":"publisher","first-page":"e26099","DOI":"10.1002\/jia2.26099","volume":"26","author":"SM Graham","year":"2023","unstructured":"Graham SM, Barthold D, Hauber B, Brah AT, Saldarriaga E, Collier AC, et al. U.S. Patient preferences for long-acting HIV treatment: a discrete choice experiment. J Int AIDS Soc. 2023;26(Suppl 2):e26099.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"12804_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JFP Bridges","year":"2011","unstructured":"Bridges JFP, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in Health\u2014a checklist: A report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403\u201313.","journal-title":"Value Health"},{"issue":"C","key":"12804_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jocm.2015.09.001","volume":"16","author":"JC Yang","year":"2015","unstructured":"Yang JC, Johnson FR, Kilambi V, Mohamed AF. Sample size and utility-difference precision in discrete-choice experiments: A meta-simulation approach. J Choice Modelling. 2015;16(C):50\u20137.","journal-title":"J Choice Modelling"},{"issue":"1","key":"12804_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12879-025-10546-w","volume":"25","author":"EM Saldarriaga","year":"2025","unstructured":"Saldarriaga EM, Hauber B, Barthold D, Brah AT, Tran J, Marconi VC, et al. Patient preferences for long-acting HIV treatment: a preference heterogeneity assessment. BMC Infect Dis. 2025;25(1):237.","journal-title":"BMC Infect Dis"},{"key":"12804_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12879-024-09309-w","volume":"24","author":"A Kaggiah","year":"2024","unstructured":"Kaggiah A, Maina CN, Kinuthia J, Barthold D, Hauber B, Tran J, et al. Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya. BMC Infect Dis. 2024;24:415.","journal-title":"BMC Infect Dis"},{"key":"12804_CR30","doi-asserted-by":"crossref","unstructured":"Maina CN, Kaggiah AW, Barthold D, Tran J, Saldarriaga EM, Simoni JM, et al. Adaptation and pilot testing of a discrete choice experiment and survey on patient preferences for long-acting antiretroviral therapies for HIV in Kenya. AIDS Care. 2025;1\u201315.","DOI":"10.1080\/09540121.2025.2587906"},{"issue":"1","key":"12804_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/09540120802032627","volume":"21","author":"SC Kalichman","year":"2009","unstructured":"Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV\/AIDS: the internalized AIDS-Related stigma scale. AIDS Care. 2009;21(1):87\u201393.","journal-title":"AIDS Care"},{"key":"12804_CR32","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"12804_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"4","key":"12804_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"AB Hauber","year":"2016","unstructured":"Hauber AB, Gonz\u00e1lez JM, Groothuis-Oudshoorn CGM, Prior T, Marshall DA, Cunningham C, et al. Statistical methods for the analysis of discrete choice experiments: A report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300\u201315.","journal-title":"Value Health"},{"issue":"11","key":"12804_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2352-4642(22)00219-X","volume":"6","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ma B, Han X, Ding S, Li Y. Global, regional, and National burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10\u201324 years from 1990 to 2019: a trend analysis based on the global burden of disease study 2019. Lancet Child Adolesc Health. 2022;6(11):763\u201376.","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"12804_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jadohealth.2023.05.006","volume":"73","author":"Improving Outcomes for Adolescents and Young Adults Living With HIV","year":"2023","unstructured":"Improving Outcomes for Adolescents and Young Adults Living With HIV. J Adolesc Health. 2023;73(3):605\u20139.","journal-title":"J Adolesc Health"},{"key":"12804_CR37","unstructured":"National AIDS & STI Control Program, Ministry of Health Kenya. Kenya HIV prevention and treatment guidelines. Nairobi: Ministry of Health; 2022 Aug [cited 2025 Nov 15]. Available from: https:\/\/hivpreventioncoalition.unaids.org\/en\/resources\/kenya-hiv-prevention-and-treatment-guidelines-2022."},{"issue":"1","key":"12804_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/COH.0000000000000776","volume":"18","author":"AD Kerkhoff","year":"2023","unstructured":"Kerkhoff AD, Muiruri C, Geng EH, Hickey MD. A world of choices: preference elicitation methods for improving the delivery and uptake of HIV prevention and treatment. Curr Opin HIV AIDS. 2023;18(1):32\u201345.","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"12804_CR39","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s10461-022-03949-2","volume":"27","author":"E Toska","year":"2023","unstructured":"Toska E, Zhou S, Chen-Charles J, Gittings L, Operario D, Cluver L. Factors associated with preferences for Long-Acting injectable antiretroviral therapy among adolescents and young people living with HIV in South Africa. AIDS Behav. 2023;27(7):2163\u201375.","journal-title":"AIDS Behav"},{"key":"12804_CR40","doi-asserted-by":"publisher","first-page":"232595822110005","DOI":"10.1177\/23259582211000517","volume":"20","author":"JM Simoni","year":"2021","unstructured":"Simoni JM, Beima-Sofie K, Wanje G, Mohamed ZH, Tapia K, McClelland RS, et al. Lighten this burden of ours: acceptability and preferences regarding injectable antiretroviral treatment among adults and youth living with HIV in coastal Kenya. J Int Assoc Provid AIDS Care. 2021;20:23259582211000516.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"6","key":"12804_CR41","doi-asserted-by":"publisher","first-page":"e0234666","DOI":"10.1371\/journal.pone.0234666","volume":"15","author":"D Kerrigan","year":"2020","unstructured":"Kerrigan D, Sanchez Karver T, Muraleetharan O, Savage V, Mbwambo J, Donastorg Y, et al. A dream come true: perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania. PLoS ONE. 2020;15(6):e0234666.","journal-title":"PLoS ONE"},{"key":"12804_CR42","unstructured":"Colson AE, Crofoot GE, Ruane PJ, Ramgopal MN. Once-weekly islatravir plus lenacapavir in virologically suppressed PWH: week 48 safety, efficacy, and metabolic changes [Internet]. In: HIV Drug Therapy Glasgow; 2024; Glasgow, Scotland. [cited 2024]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jia2.26370."},{"issue":"10","key":"12804_CR43","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1097\/QAD.0000000000003620","volume":"37","author":"D Barthold","year":"2023","unstructured":"Barthold D, Saldarriaga EM, Brah AT, Hauber B, Banerjee P, Fuller SM, et al. Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV. AIDS. 2023;37(10):1545\u201353.","journal-title":"AIDS"},{"issue":"11","key":"12804_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/apc.2018.0101","volume":"32","author":"S Shangani","year":"2018","unstructured":"Shangani S, Naanyu V, Operario D, Genberg B. Stigma and Healthcare-Seeking practices of men who have sex with men in Western kenya: A Mixed-Methods approach for scale validation. AIDS Patient Care STDS. 2018;32(11):477\u201386.","journal-title":"AIDS Patient Care STDS"},{"issue":"0 3","key":"12804_CR45","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.1097\/QAD.0000000000000846","volume":"29","author":"AM Secor","year":"2015","unstructured":"Secor AM, Wahome E, Micheni M, Rao D, Simoni JM, Sanders EJ, et al. Depression, substance abuse and stigma among men who have sex with men in coastal Kenya. AIDS. 2015;29(0 3):S251\u20139.","journal-title":"AIDS"},{"issue":"6","key":"12804_CR46","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00038-020-01370-x","volume":"65","author":"MA Stockton","year":"2020","unstructured":"Stockton MA, Pence BW, Mbote D, Oga EA, Kraemer J, Kimani J, et al. Associations among experienced and internalized stigma, social support, and depression among male and female sex workers in Kenya. Int J Public Health. 2020;65(6):791\u20139.","journal-title":"Int J Public Health"},{"issue":"1","key":"12804_CR47","doi-asserted-by":"publisher","first-page":"e0228148","DOI":"10.1371\/journal.pone.0228148","volume":"15","author":"M Rabkin","year":"2020","unstructured":"Rabkin M, Strauss M, Mantell JE, Mapingure M, Masvawure TB, Lamb MR, et al. Optimizing differentiated treatment models for people living with HIV in urban zimbabwe: findings from a mixed methods study. PLoS ONE. 2020;15(1):e0228148.","journal-title":"PLoS ONE"},{"issue":"5","key":"12804_CR48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/QAI.0000000000002070","volume":"81","author":"I Eshun-Wilson","year":"2019","unstructured":"Eshun-Wilson I, Mukumbwa-Mwenechanya M, Kim HY, Zannolini A, Mwamba CP, Dowdy D, et al. Differentiated care preferences of stable patients on antiretroviral therapy in zambia: A discrete choice experiment. J Acquir Immune Defic Syndr. 2019;81(5):540\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"12804_CR49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.5588\/ijtld.17.0596","volume":"22","author":"AM M\u00fcller","year":"2018","unstructured":"M\u00fcller AM, Os\u00f3rio CS, Silva DR, Sbruzzi G, de Tarso P, Dalcin R. Interventions to improve adherence to tuberculosis treatment: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2018;22(7):731\u201340.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"12804_CR50","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1007\/s10461-020-02929-8","volume":"24","author":"M Murray","year":"2020","unstructured":"Murray M, Antela A, Mills A, Huang J, J\u00e4ger H, Bernal E, et al. Patient-Reported outcomes in ATLAS and FLAIR participants on Long-Acting regimens of cabotegravir and rilpivirine over 48 weeks. AIDS Behav. 2020;24(12):3533\u201344.","journal-title":"AIDS Behav"},{"key":"12804_CR51","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1186\/s12879-024-09904-x","volume":"24","author":"K Konishi","year":"2024","unstructured":"Konishi K, Onozuka D, Okubo M, Kasamatsu Y, Kutsuna S, Shirano M. Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting. BMC Infect Dis. 2024;24:979.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12804_CR52","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s12879-024-09748-5","volume":"24","author":"H Zakumumpa","year":"2024","unstructured":"Zakumumpa H, Alinaitwe A, Kyomuhendo M, Nakazibwe B. Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda. BMC Infect Dis. 2024;24(1):876.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12804_CR53","doi-asserted-by":"publisher","first-page":"21484","DOI":"10.7448\/IAS.19.1.21484","volume":"19","author":"A Grimsrud","year":"2016","unstructured":"Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):21484.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"12804_CR54","doi-asserted-by":"publisher","first-page":"969","DOI":"10.7326\/M23-0788","volume":"176","author":"M Gandhi","year":"2023","unstructured":"Gandhi M, Hickey M, Imbert E, Grochowski J, Mayorga-Munoz F, Szumowski JD, et al. Demonstration project of Long-Acting antiretroviral therapy in a diverse population of people with HIV. Ann Intern Med. 2023;176(7):969\u201374.","journal-title":"Ann Intern Med"},{"issue":"1","key":"12804_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/cid\/ciad511","volume":"78","author":"JB Brock","year":"2024","unstructured":"Brock JB, Herrington P, Hickman M, Hickman A. Long-acting injectable Cabotegravir\/Rilpivirine effective in a small patient cohort with virologic failure on oral antiretroviral therapy. Clin Infect Dis. 2024;78(1):122\u20134.","journal-title":"Clin Infect Dis"},{"key":"12804_CR56","doi-asserted-by":"crossref","unstructured":"Hickey MD, Gistand N, Grochowski J, Mayorga-Munoz F, Imbert E, Szumowski JD, et al. Viral suppression rates at 48 weeks in people with human immunodeficiency virus starting long-acting cabotegravir\/rilpivirine with initial viremia. Clin Infect Dis. 2024;ciae500.","DOI":"10.1093\/cid\/ciae500"},{"issue":"12","key":"12804_CR57","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jama.2024.2985","volume":"331","author":"PE Sax","year":"2024","unstructured":"Sax PE, Thompson MA, Saag MS, IAS-USA Treatment Guidelines Panel. Updated treatment recommendation on use of cabotegravir and rilpivirine for people with HIV from the IAS-USA guidelines panel. JAMA. 2024;331(12):1060\u20131.","journal-title":"JAMA"},{"issue":"11","key":"12804_CR58","doi-asserted-by":"publisher","first-page":"e668","DOI":"10.1016\/S2352-3018(21)00184-3","volume":"8","author":"C Orkin","year":"2021","unstructured":"Orkin C, Bernal Morell E, Tan DHS, Katner H, Stellbrink HJ, Belonosova E, et al. Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study. Lancet HIV. 2021;8(11):e668\u201378.","journal-title":"Lancet HIV"},{"issue":"Suppl 1","key":"12804_CR59","doi-asserted-by":"publisher","first-page":"e26282","DOI":"10.1002\/jia2.26282","volume":"27","author":"N Nguyen","year":"2024","unstructured":"Nguyen N, Lane B, Golub SA, Chastain C, Zucker J, King K, et al. Long-acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI UP project. J Int AIDS Soc. 2024;27(Suppl 1):e26282.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"12804_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s43058-024-00631-7","volume":"5","author":"AMA Agovi","year":"2024","unstructured":"Agovi AMA, Thompson CT, Craten KJ, Fasanmi E, Pan M, Ojha RP, et al. Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system. Implement Sci Commun. 2024;5(1):93.","journal-title":"Implement Sci Commun"},{"key":"12804_CR61","unstructured":"Clinton Health Access Initiative, Inc. 2024 CHAI HIV Market Report. Boston, MA: Clinton Health Access Initiative; 2024 Dec [cited 2025 Jan 27]. Report No. 15. Available from: https:\/\/www.clintonhealthaccess.org\/wp-content\/uploads\/2024\/12\/2024-HIV-Market-Report_12.20.24.pdf."},{"key":"12804_CR62","doi-asserted-by":"crossref","unstructured":"Byanyima W, Bekker LG, Kavanagh MM, Long-acting HIV. Medicines and the pandemic inequality cycle \u2014 rethinking access. In: Malina D, editor. N Engl J Med. 2025;392(1):90\u20136.","DOI":"10.1056\/NEJMms2412286"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12804-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:03:18Z","timestamp":1773799398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12804"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12804-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Washington (UW, STUDY00013593) and Kenyatta National Hospital-University of Nairobi Ethics and Research committee (P458\/06\/2021) reviewed and approved the study protocol and informed consent documents. The study adhered to the Declaration of Helsinki. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BH is an employee of Pfizer, but Pfizer had no input or influence on the study. SMG has received support from Gilead and Cepheid for her research. The other authors declare that they have no conflicts of interest directly relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"570"}}